EPS3.3 Plasma levels of the bioactive sphingolipid S1P are reduced in cystic fibrosis patients after lung transplantation depending on CFTR mutation.
Saved in:
| Title: | EPS3.3 Plasma levels of the bioactive sphingolipid S1P are reduced in cystic fibrosis patients after lung transplantation depending on CFTR mutation. |
|---|---|
| Authors: | Halilbasic, E., Fuerst, E., Heiden, D., Japtok, L., Diesner, S.C., Hillebrand, P., Vogelsang, H., Trauner, M., Kulu, A., Jaksch, P., Klepetko, W., Kleuser, B., Kazemi-Shirazi, L., Untersmayr, E. |
| Source: | Journal of Cystic Fibrosis. Jun2017 Supplement 1, Vol. 16, pS41-S42. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
